Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention
-
Published:2024-09
Issue:3
Volume:231
Page:330.e1-330.e14
-
ISSN:0002-9378
-
Container-title:American Journal of Obstetrics and Gynecology
-
language:en
-
Short-container-title:American Journal of Obstetrics and Gynecology
Author:
Dioun Shayan M.,
Perez Luiza R.,
Prabhu Malavika,
Brewer Jesse T.ORCID,
Ahsan Muhammad D.,
Hou June Y.,
Sharaf Ravi N.,
Wright Jason D.,
Frey Melissa K.
Reference28 articles.
1. Population-based screening for BRCA1 and BRCA2: 2014 Lasker award;King;JAMA,2014
2. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017
3. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Dwyer;J Natl Compr Canc Netw,2021
4. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA,2010
5. Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States;Guzauskas;JAMA Netw Open,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献